Clinical Trials Browser

Epirubicin × Gastrointestinal × 1 year × Clear all

NCT01630083 2025-06-15

FAST

Phase 2 Completed

Gastrointestinal

CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction